Development of mobile technologies for the prevention of cervical cancer in Santiago, Chile study protocol: a randomized controlled trial

BACKGROUND: In Chile, more than 500 women die every year from cervical cancer, and a majority of Chilean women are not up-to-date with their Papanicolau (Pap) test. Mobile health has great potential in many health areas, particularly in health promotion and prevention. There are no randomized contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Momany, McKenzie C., Martinez-Gutierrez, Javiera, Soto, Mauricio, Capurro, Daniel, Ciampi, Francis, Thompson, Beti, Puschel, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729241/
https://www.ncbi.nlm.nih.gov/pubmed/29237420
http://dx.doi.org/10.1186/s12885-017-3870-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729241/
https://www.ncbi.nlm.nih.gov/pubmed/29237420
http://dx.doi.org/10.1186/s12885-017-3870-8

Ejemplares similares